[1]CurrentPatentAssignee:SANOFI-WO2013/190123,2013,A1
[2]CurrentPatentAssignee:SANOFI-US2015/183804,2015,A1
[1]CurrentPatentAssignee:OCUTERRATHERAPEUTICSINC-WO2016/134223,2016,A2Locationinpatent:Page/Pagecolumn67
1214345-30-8
13472-85-0
1079352-13-8
2089319-24-2
1086393-00-1
914299-59-5 | 3-(3-Chlorophenyl)pyrrolidine | AA00GVB4 | MFCD09027611
886504-11-6 | N-(Piperidin-3-yl)propanamide | AA00GVFN | MFCD06740161
938459-14-4 | 1-(3-Aminophenyl)imidazolidin-2-one | AA00GVJY | MFCD09055391
889943-47-9 | 3-(3-piperidinyl)[1,2,4]triazolo[4,3-a]pyridine | AA00GVOS | MFCD08166724
926194-19-6 | N-(5-amino-2-methoxyphenyl)-2-methoxyacetamide | AA00GVTK | MFCD09042662
92659-90-0 | 2-[(Azidoacetyl)aMino]-2-deoxy-D-glucose | AA00GW6C | MFCD22683766
86620-70-4 | 4-(PIPERAZINOMETHYL)BENZOIC ACID, DIHYDROCHLORIDE | AA00GWPY | MFCD09753579
918149-29-8 | Argininosuccinic acid hydrate disodium salt | AA00GX9N | MFCD11656132
915945-40-3 | 3-Cyano-4-(3-chloro-4-fluoroanilino)-7-ethoxy-6-(phthaliMidyl)quinoline | AA00GXRN | MFCD18379301
936348-97-9 | 1,3-Benzodiazol-1-ylacetic acid hydrochloride | AA00GY7I | MFCD08163106